Status:

COMPLETED

CoPPer Study - Complications of Polycystic Ovary Syndrome (PCOS) Pregnancy: Evaluating Risk

Lead Sponsor:

UMC Utrecht

Collaborating Sponsors:

The Queen Elizabeth Hospital

Erasmus Medical Center

Conditions:

Pregnancy Complications

Delivery Complications

Eligibility:

FEMALE

18-40 years

Brief Summary

The CoPPer study is a follow-up study of women diagnosed with Polycystic Ovary Syndrome (PCOS). Women will be included pre-conceptional and followed-up until after delivery. The investigators will des...

Detailed Description

Background of the study: PCOS is a heterogeneous condition in which metabolic disturbances such as insulin resistance are common. Pregnancies in women with PCOS are reported to have an increased chan...

Eligibility Criteria

Inclusion

  • Women with PCOS
  • 18 to 40 years old, who wish to conceive.

Exclusion

  • Women with anovulation that is not caused by PCOS
  • Women with a language barrier
  • Women under 18 or over 40 years of age will be excluded from participation.
  • Other exclusion criteria are:
  • Unresolved medical conditions
  • Established type 1 diabetes.

Key Trial Info

Start Date :

April 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2012

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00821379

Start Date

April 1 2008

End Date

September 1 2012

Last Update

December 20 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UMC Utrecht

Utrecht, Utrecht, Netherlands, 3508 GA